| Salmon Pharma GmbH - Medikinet MR 20 mg, Kapseln | | 56847 | | 06 | | Medikinet MR 20 mg | | Kapseln | | N06BA04 | | Methylphenidat | | 14.11.2008 | | |
| | Composition | | methylphenidati hydrochloridum 20 mg, sacchari sphaerae corresp. saccharum 114.65-131.13 mg et maydis amylum, poly(alcohol vinylicus), macrogolum 3350, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, polysorbatum 80, natrii laurilsulfas, natrii hydroxidum, triethylis citras, simeticonum, methylcellulosum, silica colloidalis anhydrica, E 132, aluminii oxidum hydricum, E 200, Kapselhülle: gelatina, natrii laurilsulfas, aqua purificata, E 127, E 131, E 171 pro capsula corresp. natrium 0.09 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Methylphenidate Hydrochloride | 20 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Methylphenidate Hydrochloride | 20 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidi Methacrylici | | | | Aluminii Oxidum Hydricum | | | | Aqua Purificata | | | | E 127 | | color. | | E 131 | | color. | | E 132 | | color. | | E 171 | | color. | | E 200 | | conserv. | | Ethylis Acrylatis Polymerisatum | | | | Gelatina | | Kapselhülle | | Macrogol | 3350 | | | Maydis Amylum | | | | Methylcellulosum | | | | Sodium Hydroxide | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | | | Polysorbatum 80 | | | | Sacchari Sphaerae | | | | Silica Colloidalis Anhydrica | | | | Simeticone | | | | Talcum | | | | Triethylis Citras | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 30 Gélule(s) | | | A+ | | Oui | | 038 | 20 Gélule(s) | | | A+ | | Oui | | 039 | 50 Gélule(s) | 34.57 | 54.00 | A+ | LS | Non | | 040 | 100 Gélule(s) | 60.85 | 82.60 | A+ | LS | Non |
|
|
